Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 61.13B | 61.49B | 59.14B | 57.08B | 51.78B |
Gross Profit | 12.43B | 11.97B | 10.76B | 10.32B | 9.34B |
EBITDA | 7.63B | 7.18B | 5.32B | 4.81B | 3.99B |
Net Income | 3.30B | 3.17B | 2.47B | 2.18B | 1.60B |
Balance Sheet | |||||
Total Assets | 64.55B | 64.71B | 57.77B | 56.02B | 54.06B |
Cash, Cash Equivalents and Short-Term Investments | 12.19B | 12.44B | 16.37B | 16.18B | 16.95B |
Total Debt | 5.87B | 7.00B | 6.84B | 6.34B | 6.37B |
Total Liabilities | 23.38B | 24.26B | 22.66B | 22.51B | 23.33B |
Stockholders Equity | 39.21B | 38.67B | 33.45B | 31.97B | 29.42B |
Cash Flow | |||||
Free Cash Flow | 4.16B | 4.96B | 3.57B | 1.28B | 2.75B |
Operating Cash Flow | 4.84B | 5.54B | 4.49B | 2.03B | 3.25B |
Investing Cash Flow | -1.04B | -219.00M | -1.17B | -613.00M | -409.00M |
Financing Cash Flow | -4.68B | -2.83B | -2.53B | -1.58B | -928.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥39.74B | 11.27 | 5.26% | -1.40% | 0.05% | ||
80 Outperform | ¥27.38B | 16.06 | 2.49% | 4.91% | 1.63% | ||
78 Outperform | ¥9.80B | 12.96 | 2.14% | 3.59% | 3.84% | ||
76 Outperform | ¥13.51B | 14.12 | 2.08% | 15.85% | 16.36% | ||
76 Outperform | ¥14.75B | 15.93 | 1.30% | 2.95% | 6.31% | ||
73 Outperform | ¥5.24B | 6.08 | 2.24% | 0.16% | 100.58% | ||
66 Neutral | £2.68B | 13.05 | 3.30% | 3.25% | 2.40% | -22.21% |